SCHEMBL30990197

SCHEMBL30990197

CCOC(=O)c1[nH]c2cc(Cl)oc2c1I

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 12/20 0.44
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 3/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ XBP1 P17861 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30990295 0.81 ALOX15 (0.44) ALOX15ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL8253165 0.75 KDM4E (0.43) ALOX15ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL26213307 0.73 ALOX15 (0.70) ALOX15ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL829181 0.73 ALDH1A1 (0.66) ALOX15ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL30990230 0.72 ALDH1A1 (0.46) ALOX15ALDH1A1HPGDKDM4ENPC1
SCHEMBL1245121 0.70 ALOX15 (0.55) ALOX15ALDH1A1HPGDKDM4ENPC1
SCHEMBL4791633 0.70 CYP1A2 (0.56) ALDH1A1HPGDCYP1A2CYP2C19MAPT
SCHEMBL1244859 0.70 KDM4E (0.38) ALOX15ALDH1A1HPGDCYP1A2KDM4E
SCHEMBL2351650 0.69 GABRA1 (0.60) ALOX15ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL830378 0.69 ALDH1A1 (0.71) ALDH1A1HPGDCYP1A2CYP2C19XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626860-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS ReWind Therapeutics NV (BE) 2025-10-08 — — EP disclosed
WO-2024115733-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS REWIND THERAPEUTICS NV (BE) 2024-06-06 — — WO disclosed
Send feedback